[{"address1": "Bahnhofstrasse 7", "city": "Zug", "zip": "6300", "country": "Switzerland", "phone": "41 41 711 9325", "website": "https://oculis.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.", "fullTimeEmployees": 36, "companyOfficers": [{"maxAge": 1, "name": "Dr. Riad  Sherif M.B.A., M.D.", "age": 56, "title": "CEO & Director", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sylvia  Cheung", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gudrun  Bachmann Ph.D.", "title": "Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ramin  Tadayoni M.D., Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel S. Char J.D.", "age": 63, "title": "Chief Legal Officer", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Virginia R. Dean", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. P\u00e1ll Ragnar J\u00f3hannesson", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Weil", "title": "Chief Commercial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Snehal  Shah Pharm.D.", "title": "President of Research & Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sharon  Klier M.D., M.P.H.", "title": "Chief Development Officer", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.7, "open": 18.66, "dayLow": 18.36, "dayHigh": 18.78, "regularMarketPreviousClose": 18.7, "regularMarketOpen": 18.66, "regularMarketDayLow": 18.36, "regularMarketDayHigh": 18.78, "payoutRatio": 0.0, "beta": 0.051, "forwardPE": -8.379464, "volume": 72020, "regularMarketVolume": 72020, "averageVolume": 74660, "averageVolume10days": 50500, "averageDailyVolume10Day": 50500, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 900960000, "fiftyTwoWeekLow": 10.55, "fiftyTwoWeekHigh": 23.08, "priceToSalesTrailing12Months": 1037.9723, "fiftyDayAverage": 20.6878, "twoHundredDayAverage": 15.25313, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 667557632, "profitMargins": 0.0, "floatShares": 34761483, "sharesOutstanding": 48000000, "sharesShort": 24987, "sharesShortPriorMonth": 12814, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.06425, "heldPercentInstitutions": 0.25621998, "shortRatio": 0.43, "shortPercentOfFloat": 0.00059999997, "impliedSharesOutstanding": 49362400, "bookValue": 2.27, "priceToBook": 8.268723, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -69621000, "trailingEps": -2.4, "forwardEps": -2.24, "enterpriseToRevenue": 769.076, "enterpriseToEbitda": -9.817, "52WeekChange": 0.58396626, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 18.77, "targetHighPrice": 40.92533, "targetLowPrice": 22.002804, "targetMeanPrice": 31.918636, "targetMedianPrice": 31.941084, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 105473000, "totalCashPerShare": 2.515, "ebitda": -68003000, "totalDebt": 1243000, "quickRatio": 3.862, "currentRatio": 4.022, "totalRevenue": 868000, "debtToEquity": 1.305, "revenuePerShare": 0.022, "returnOnAssets": -0.33455002, "returnOnEquity": -0.69333, "grossProfits": -47481000, "freeCashflow": -26354124, "operatingCashflow": -50158000, "revenueGrowth": -0.014, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -83.93981, "financialCurrency": "CHF", "symbol": "OCS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_589165623", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.3743299, "regularMarketPrice": 18.77, "shortName": "Oculis Holding AG", "longName": "Oculis Holding AG", "corporateActions": [], "postMarketTime": 1741982711, "regularMarketTime": 1741982401, "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 74660, "fiftyTwoWeekLowChange": 8.22, "fiftyTwoWeekLowChangePercent": 0.7791469, "fiftyTwoWeekRange": "10.55 - 23.08", "fiftyTwoWeekHighChange": -4.3099995, "fiftyTwoWeekHighChangePercent": -0.18674174, "fiftyTwoWeekChangePercent": 58.396626, "earningsTimestamp": 1741770000, "earningsTimestampStart": 1741770000, "earningsTimestampEnd": 1741770000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.4, "epsForward": -2.24, "epsCurrentYear": -1.69951, "priceEpsCurrentYear": -11.04436, "fiftyDayAverageChange": -1.917799, "fiftyDayAverageChangePercent": -0.092701934, "twoHundredDayAverageChange": 3.5168705, "twoHundredDayAverageChangePercent": 0.23056714, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-03-03", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1621344600000, "postMarketChangePercent": 0.0, "postMarketPrice": 18.77, "postMarketChange": 0.0, "regularMarketChange": 0.069999695, "regularMarketDayRange": "18.36 - 18.78", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]